Adaptive radiotherapy in lung cancer: dosimetric benefits and clinical outcome - Wikidata - awgldk - TriplyDB

Adaptive radiotherapy in lung cancer: dosimetric benefits and clinical outcome

Adaptive radiotherapy in lung cancer: dosimetric benefits and clinical outcome

http://www.wikidata.org/entity/Q33823123

about

Radiation-induced heart disease in lung cancer radiotherapy: A dosimetric update.Classification of changes occurring in lung patient during radiotherapy using relative γ analysis and hidden Markov models.Biomechanical deformable image registration of longitudinal lung CT images using vessel information.Magnetic resonance imaging in precision radiation therapy for lung cancer.Treating locally advanced lung cancer with a 1.5T MR-Linac - Effects of the magnetic field and irradiation geometry on conventionally fractionated and isotoxic dose-escalated radiotherapy.Physiological gas exchange mapping of hyperpolarized 129 Xe using spiral-IDEAL and MOXE in a model of regional radiation-induced lung injury.Mitigating differential baseline shifts in locally advanced lung cancer patients using an average anatomy model.Dosimetric benefit of adaptive radiotherapy in the neoadjuvant management of canine and feline thymoma-An exploratory case series.A feasibility study of dynamic adaptive radiotherapy for nonsmall cell lung cancer.

P2860

Q30244586-B612B988-7793-4168-8243-D0902A7B46BC Q38661000-CC9F6140-7ECB-4994-8364-40BDF5EFC8C3 Q38856745-2A7BB481-2F21-4C55-B941-7D7B8BB62827 Q47108915-687D6792-B980-4E4C-A87D-09F83ACCD520 Q47163187-3430E704-A143-4786-845F-D77857E99C2C Q47562831-0B8C8256-6A82-4ADB-BE18-A2FE7779976A Q47891054-51EA5BFA-72F1-4D99-9E76-27168ED607C0 Q48280327-889B0851-B001-48EA-A16B-C34DC17441C3 Q50652930-37F3628E-3DA2-4A11-A850-66C87A327E1D

P2860

Adaptive radiotherapy in lung cancer: dosimetric benefits and clinical outcome

http://www.wikidata.org/entity/Q33823123

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Adaptive radiotherapy in lung cancer: dosimetric benefits and clinical outcome

@ast

Adaptive radiotherapy in lung cancer: dosimetric benefits and clinical outcome

@en

type

label

Adaptive radiotherapy in lung cancer: dosimetric benefits and clinical outcome

@ast

Adaptive radiotherapy in lung cancer: dosimetric benefits and clinical outcome

@en

prefLabel

Adaptive radiotherapy in lung cancer: dosimetric benefits and clinical outcome

@ast

Adaptive radiotherapy in lung cancer: dosimetric benefits and clinical outcome

@en

P1433

Q33823123-9564B259-481E-4921-941E-AC622FC50253

P1476

Q33823123-EE2073B5-8223-4992-A4F8-235A96F490C0

P2093

Q33823123-0A23AB96-B88D-4DD2-9D89-A6EE38CC9C7F

Q33823123-18620C7D-5D74-4DB7-8D76-A8F212EEAC34

Q33823123-1BCB1400-7297-4589-9FFA-3AABCACC706E

Q33823123-3355B1C7-61D5-4D75-9137-D94FFAD476CD

Q33823123-46FEE643-8229-4E1B-B93F-4C450FDDE9FB

Q33823123-68753B00-E931-4FBF-B254-F5B989C6B5D8

Q33823123-87033752-36E8-494D-9FC9-227F6C9C20F1

Q33823123-97251427-3B58-44FC-A480-6BCA6FD2BF91

Q33823123-A26E993A-EC99-433E-A3F0-F3EAF183F757

Q33823123-C3C59DE8-C8F8-4208-A5BE-A8DF4AB980D7

P2860

Q33823123-138CAF82-474C-469E-944D-C8DA3E0F4CE6

Q33823123-3B1BDACD-C4AB-4164-AA76-B323A29767AA

Q33823123-4349E9F4-B571-4C34-A655-E85AF60514A9

Q33823123-44112DE9-6F30-4058-AB93-686DF3ECB9E4

Q33823123-461BAD1B-1CFA-4110-8745-E7E0D9FAE5D2

Q33823123-46B18030-0622-42E8-81E8-4759BB24F937

Q33823123-546DA8E7-D966-458A-88B6-4FB656173B5B

Q33823123-59EA37C6-4979-4129-A2C3-870D3CC43C54

Q33823123-5B37E36E-255C-45F2-B3AC-A3435AAAFA52

Q33823123-5F335CCD-A56D-4CCB-8520-C3DD11286A1C

P304

Q33823123-160B9820-0A93-4E6A-8C87-C5988AB03AF9

P31

Q33823123-DFDC65D1-BE0E-479B-B1F4-FB9175178D99

P356

Q33823123-5B2177EF-6297-48F7-9927-4D03E6850B41

P407

Q33823123-04DABFB4-A91B-495F-9DC3-88CE18210242

P433

Q33823123-2250097D-3027-4199-91C4-779011958270

P478

Q33823123-38DFA9C4-F6AA-4D90-81B1-381E95FDFD91

P50

Q33823123-8B2C88D7-F48D-4127-87AD-7F2A8CEFF129

P577

Q33823123-9F87AD43-31EB-425F-9908-0FC68A0FCD60

P5875

Q33823123-6101A979-FECA-48C3-A34E-B1AF0D2A1BC1

P698

Q33823123-EC42C5CA-A78E-4773-8BAC-FE34418B82A0

P932

Q33823123-B8CC939F-F776-4F4A-A98F-63665F03E712

P356

P1433

British Journal of Radiology

P1476

Adaptive radiotherapy in lung cancer: dosimetric benefits and clinical outcome

@en

P2093

A Abhishek

http://www.w3.org/2001/XMLSchema#string

A Srivastava

http://www.w3.org/2001/XMLSchema#string

D Gupta

http://www.w3.org/2001/XMLSchema#string

H B Govardhan

http://www.w3.org/2001/XMLSchema#string

K Sharma

http://www.w3.org/2001/XMLSchema#string

L Pushpan

http://www.w3.org/2001/XMLSchema#string

N Karthikeyan

http://www.w3.org/2001/XMLSchema#string

S Goyal

http://www.w3.org/2001/XMLSchema#string

S Jain

http://www.w3.org/2001/XMLSchema#string

S S Bisht

http://www.w3.org/2001/XMLSchema#string

P2860

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Role of adaptive radiotherapy during concomitant chemoradiotherapy for lung cancer: analysis of data from a prospective clinical trial.

Chemotherapy for non-small cell lung cancer.

Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy.

ASTRO (American Society for Therapeutic Radiology and Oncology) plenary: Effect of chemotherapy on locally advanced non-small cell lung carcinoma: a randomized study of 353 patients. GETCB (Groupe d'Etude et Traitement des Cancers Bronchiques), FNCL

A phase III randomized trial of combined chemoradiotherapy versus radiotherapy alone in locally advanced non-small-cell lung cancer.

Quantification of tumor volume changes during radiotherapy for non-small-cell lung cancer.

Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial.

Potential of adaptive radiotherapy to escalate the radiation dose in combined radiochemotherapy for locally advanced non-small cell lung cancer.

Feasibility of shrinking field radiation therapy through 18F-FDG PET/CT after 40 Gy for stage III non-small cell lung cancers.

P304

20130643

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1259/BJR.20130643

http://www.w3.org/2001/XMLSchema#string

P407

P433

1038

http://www.w3.org/2001/XMLSchema#string

P478

87

http://www.w3.org/2001/XMLSchema#string

P50

Tejinder Kataria

P577

2014-03-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260837723

http://www.w3.org/2001/XMLSchema#string

P698

24628269

http://www.w3.org/2001/XMLSchema#string

P932

4075550

http://www.w3.org/2001/XMLSchema#string